DR-TB
“Who has to do it at the end of the day? Programme officials or hospital authorities?” Airborne infection control at drug resistant tuberculosis (DR-TB) centres of Karnataka, India: a mixed-methods study
10
Research Article Active Case Finding For TB / DR- TB in Health Care Workers
8
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug resistant tuberculosis treatment outcomes in Johannesburg, South Africa
12
Do specialist pulmonologists appropriately utilise thoracic surgery for drug-resistant pulmonary tuberculosis? A survey
6
Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries
12
Epidemiological trends and outcomes of extensively drug resistant tuberculosis in Shandong, China
9
<p>Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China</p>
11
Treating drug-resistant tuberculosis in a low-intensity chronic conflict setting in India
6
Cost of three models of care for drug resistant tuberculosis patients in Nigeria
10
Spatial epidemiology and spatial ecology study of worldwide drug-resistant tuberculosis
10
<p>Determinants of Drug-Resistant Tuberculosis in Southern Ethiopia: A Case–Control Study</p>
7
Improvement in tuberculosis infection control practice via technical support in two regions of Ethiopia
7
Incidence and predictors of lost to follow up among drug resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow up study
11
The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
15
Diagnosing Drug Resistant Tuberculosis with the Xpert®MTB/RIF The Risk for Rifampin Susceptible Cases
7
Drug resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing
6
Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi centric prospective study
7
Addressing challenges in tuberculosis adherence via performance based payments for integrated case management: protocol for a cluster randomized controlled trial in Georgia
13
Rationing tests for drug-resistant tuberculosis – who are we prepared to miss?
9
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015
12